Bone Biologics Corp (BBLGW)
2025-06-30 | ||||
|---|---|---|---|---|
| Revenues | - | |||
| Research and development | 191,608 | |||
| General and administrative | 556,467 | |||
| Total operating expenses | 748,075 | |||
| Loss from operations | -748,075 | |||
| Interest income | 6,654 | |||
| Change in fair value of warrant liability | -902 | |||
| Total other income | 7,556 | |||
| Net loss | -740,519 | |||
| Loss per share - basic | -1.33 | |||
| Loss per share - diluted | -1.33 | |||
| Weighted average shares outstanding - basic | 557,787 | |||
| Weighted average shares outstanding - diluted | 557,787 | |||